Patients who have experienced anaphylaxis should be offered a referral to a specialist allergy service, which includes healthcare professionals with the skills to investigate, diagnose, monitor, and provide ongoing management and patient education about suspected anaphylaxis NICE CG134.
Before discharge, a healthcare professional should provide information about anaphylaxis, including signs and symptoms, risk of biphasic reactions, and what to do if a reaction occurs, such as using an adrenaline injector and calling emergency services NICE CG134.
Patients should be given a brand-specific demonstration of the correct use of the adrenaline injector, advised to carry two injectors at all times, and instructed on avoiding triggers if known NICE CG134.
Each hospital trust should have referral pathways for suspected anaphylaxis in adults and children NICE CG134.
After emergency treatment, patients should be observed for 6 to 12 hours depending on their response, with children younger than 16 being admitted under paediatric care NICE CG134.
Patients should also be provided with an interim adrenaline injector before their specialist appointment and be educated on recognition and management of future reactions NICE CG134.